Lilly expects full-year earnings in the range of $22.50 to $24 per share, with revenue in the range of $58 billion to $61 billion. This story was generated by Automated Insights ( ...

Indiana's workforce is feeling pressure to return to the office, but a good portion of employees still like hybrid work. Is ...

Sales of Lilly’s top-selling product, the diabetes treatment Mounjaro, jumped 60% to $3.53 billion in the final quarter of ...

Eli Lilly & Company Chairman and CEO Dave Ricks sheds light on growth and success, the increase in weight loss drug ...

Eli Lilly forecast annual profit largely above Wall Street estimates on Thursday, banking on the launch of its popular ...

Purdue announced an exciting new collaboration and earned accolades for several online programs this week. Derek Schultz has it all in the latest edition of “Purdue News Now” from Indianapolis. Plus, ...

Leerink Partners analyst David Risinger maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) on January 24 and set a price ...

Citi analyst Geoff Meacham maintained a Buy rating on Eli Lilly & Co (LLY – Research Report ... The company is headquartered in Indianapolis, Indiana. Read More on LLY: Eli Lilly NewsMORE ...

(WAVE) - Eli Lilly and Company, a pharmaceutical company headquartered in Indianapolis, plans to investment more at the LEAP Research and ... facility will be a new center for drug development ...

Kristin Sherman has worked in nearly every part of Indiana’s health care and life sciences world, from drugmaker Eli Lilly and Co ... money and developing research? We were formed in 2020 ...

Eli Lilly and Co., which cemented its place in Boston last year with the opening of a new research and development center, is now buying a cancer program from a Boston biotech. Eli Lilly and Co ...